Jason Dorr, PharmD Associate

Jason Dorr, PharmD, is an Associate at HCRx. Dr. Dorr primarily supports HCRx’s research efforts. Dr. Dorr also participates in HCRx’s business development and transaction-related activities, including financial analysis, transaction structuring, and due diligence. Prior to joining HCRx, Dr. Dorr was a biotechnology equity research associate at Oppenheimer & Co, covering SMID-cap equities in endocrinology, immunology, and orphan diseases, and a consultant at L.E.K. Consulting advising on transactions and portfolio strategy for biotechnology companies. Dr. Dorr holds a PharmD from Rutgers University.